ERCC1 and ERCC2 polymorphisms predict clinical outcomes of oxaliplatin-based chemotherapies in gastric and colorectal cancer: a systemic review and meta-analysis.

Source:http://linkedlifedata.com/resource/pubmed/id/21278243

Clin. Cancer Res. 2011 Mar 15 17 6 1632-40

Download in:

View as

Triples

General Info

PMID
21278243